This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
N. Anden , S. G. Butcher , H. Corrodi , K. Fuxe & U. Ungerstedt (1970). Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. European Journal of Pharmacology 11, 303–314.
H. K. H. Brodie , D. L. Murphy , F. K. Goodwin & W. E. Bunney Jr (1971). Catecholamines and mania: the effect of alpha-methyl-paratyrosine on manic behavior and catecholamine metabolism. Clinical Pharmacology and Therapeutics 12, 218–224.
W. A. Brown , D. P. Corriveau & M. H. Ebert (1978). Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology 58, 189–195.
D. Campbell (1969). A method for the measurement of therapeutic levels of (+)-amphetamine in human plasma. Journal of Pharmacy and Pharmacology 21, 129–130.
J. C. Cookson , T. Silverstone , G. M. Besser & S. Williams (1980). Plasma corticosteroids in mania: the effects of pimozide. Neuropharmacology 19, 1243–1244.
J. C. Cookson , T. Silverstone & B. Wells (1981). Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis. Acta Psychiatrica Scandinavica 64, 381–397.
J. P. Feighner , E. Robins , S. B. Guze , R. A. Woodruff , G. Winokur & R. Munoz (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57–63.
J. C. Gillin , D. P. van Kammen & W. E. Bunney (1978). Pimozide attenuates d-amphetamine-induced sleep changes in man. Life Sciences 22, 1805–1809.
D. R. Hemsley & H. C. Philips (1975). Models of mania: an individual case study. British Journal of Psychiatry 127, 78–85.
L. E. Jonsson (1972). Pharmacological blockade of amphetamine effects in amphetamine dependent subjects. European Journal of Clinical Pharmacology 4, 206–211.
L. E. Jonsson , E. Anggard & L. M. Gunne (1971). Blockade of intravenous amphetamine euphoria in man. Clinical Pharmacology and Therapeutics 12, 889–896.
W. R. Martin , J. W. Sloan , J. D. Sapira & D. R. Jasinski (1971). Physiologic, subjective, and behavioural effects of amphetamine, methamphetamine, ephedrine, pnenmetrazine, and methylpheni-date in man. Clinical Pharmacology and Therapeutics 12, 245–258.
D. Mattingly (1962). A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. Journal of Clinical Pathology 15, 374–379.
W. T. McKinney (1974). Animal models in psychiatry. Perspectives in Biology and Medicine 17, 529–541.
W. T. McKinney & W. E. Bunney (1969). Animal model of depression. Archives of General Psychiatry 21, 240–248.
L. Rees , P. W. Butler , C. Gosling & G. M. Besser (1970). Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine. Nature 228, 565–566.
M. Schou (1968). Lithium in psychiatric therapy and prophylaxis. Journal of Psychiatric Research 6, 67–95.
T. Silverstone , J. Fincham , B. Wells & M. Kyriakides (1980). The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man. Neuropharmacology 19, 1235–1237.
T. Silverstone , B. Wells & E. Trenchard (1983). Differential dose-response effects of dextroamphetamine sulphate on hunger, arousal and mood in human volunteers. Psychopharmacology 79, 242–245.
R. C. Smith & J. M. Davis (1977). Comparative effects of d-amphetamine, l-amphetamine and methylphenidate on mood in man. Psychopharmacology 53, 1–12.
D. P. Van Kammen & D. L. Murphy (1975). Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44, 215–224.